Business Development

CASES

Representative examples of our strategic alliances:

• Incorporation of one of our discoveries as the potential predictive signature for the case drug/therapy
• Proposal of a defined clinical trial for a new drug, based on one of our models
• Proposal of a new customized signature for a new drug
• Specific testing of a signature as proposed by the third party

The flow of such strategic collaborations is conducted in a framework of strict confidentiality. Project management is implemented to generate a realistic and feasible proposal, whilst staying competitive at the cost level and valuing time as a critical aspect.

Our approach to test the model in tumor/biological samples, from responders/resistant patients to the case drug/combination anticipates the possibility to generate indicative results within a short timeframe from the start of the collaboration.

Intellectual property rights are discussed in depth at the beginning of the project.